Chronic beryllium disease is a long-term lung condition caused by immune sensitivity to beryllium dust or fumes at work. People with chronic beryllium disease often have cough, shortness of breath, chest tightness, and fatigue, and early symptoms of chronic beryllium disease can be mild. It mainly affects adults exposed in industries like aerospace, machining, electronics, and mining. Diagnosis and monitoring use a blood test for beryllium sensitivity and lung imaging, and treatment usually includes corticosteroids and other medicines that calm inflammation. The outlook varies, but many people live for years with careful exposure avoidance, regular follow-up, and oxygen if needed.
Overview
Chronic beryllium diseaseSymptoms
Chronic beryllium disease causes breathlessness with activity, a dry cough, and fatigue. Early symptoms of chronic beryllium disease can include chest tightness, night sweats, and unintentional weight loss. Some people also notice fever or wheezing during flare-ups.
Outlook and prognosis
Many people with chronic beryllium disease live for years with careful monitoring and tailored treatment. Early diagnosis, avoiding further beryllium exposure, and consistent lung care can slow scarring and preserve day‑to‑day breathing. Outcomes vary; flare-ups and gradual decline can occur.
Causes and risk factors
Key risk factors for chronic beryllium disease include breathing beryllium dust or fumes, usually at work (aerospace, machining, electronics, dental alloys). Risk rises with greater exposure and poor protection, including skin cuts. A specific immune-system gene variant increases susceptibility.
Genetic influences
Genetics play a modest role in chronic beryllium disease. A specific HLA-DP variant (often written HLA-DPB1 Glu69) increases susceptibility, but exposure drives risk. Not everyone with the variant gets sick, and people without it can still develop disease.
Diagnosis
Diagnosis of chronic beryllium disease relies on a history of beryllium exposure plus testing. Doctors use the beryllium lymphocyte proliferation test (blood or bronchoalveolar lavage), lung imaging and function tests, and sometimes bronchoscopy with biopsy to confirm.
Treatment and drugs
Treatment for chronic beryllium disease focuses on easing breathing problems, calming lung inflammation, and protecting lung function. Doctors often use corticosteroids, sometimes with other immune-suppressing medicines, plus inhalers, oxygen, and pulmonary rehab. Avoiding further beryllium exposure is essential.
Symptoms
Chronic beryllium disease can sneak up gradually, often years after workplace exposure to beryllium. You may notice a slowly worsening cough or shortness of breath, especially when walking briskly or climbing stairs. Symptoms vary from person to person and can change over time.
Early symptoms of chronic beryllium disease often include getting winded faster than before. You may feel out of breath when climbing one flight of stairs or carrying groceries. Over time, this can limit exercise and daily tasks.
In chronic beryllium disease, a cough that lingers for months without much mucus is common. It may flare with exertion, cold air, or dust exposure. Some notice it’s worse at night or with laughing.
People describe a dull ache, pressure, or tightness in the chest. It may come on with activity and ease with rest. Sharp pain is less typical but can happen.
With chronic beryllium disease, many feel unusually tired, even after a full night’s sleep. Daily tasks can take more effort than before. This can affect work, hobbies, and social plans.
How people usually first notice Chronic beryllium disease?
Many people first notice chronic beryllium disease after developing a stubborn dry cough, shortness of breath with mild activity, chest tightness, or unusual fatigue that doesn’t match their fitness level. For many, the clue is a job or past work around beryllium—such as aerospace, electronics, dentistry labs, or machining—followed by breathing symptoms that linger, prompting a doctor to order breathing tests, chest imaging, and a blood test called the beryllium lymphocyte proliferation test (BeLPT). Sometimes it’s first picked up during workplace health screening before symptoms are obvious, when tests show lung inflammation suggestive of early disease.
Types of Chronic beryllium disease
Chronic beryllium disease is a progressive lung condition caused by the immune system reacting to beryllium dust or fumes, most often at work. Doctors consider it an immune-mediated form of lung inflammation that can form scar tissue over time, leading to cough and breathlessness in day-to-day activities like climbing stairs or carrying groceries. People may notice different sets of symptoms depending on their situation. When people talk about types of chronic beryllium disease, they usually mean patterns that reflect how active the immune reaction is and how much lung scarring has developed over time.
Beryllium sensitization
This is the immune system reacting to beryllium without signs of lung scarring yet. People often have no symptoms or only a mild cough or shortness of breath with exertion. It can progress to chronic beryllium disease if exposure continues.
Inflammatory active phase
The immune reaction causes granulomas—small clusters of inflammatory cells—in the lungs. This phase often brings persistent dry cough, fatigue, and breathlessness with routine activity. Chest imaging and biopsy may show inflammation without extensive scarring.
Fibrotic chronic phase
Ongoing inflammation leads to lung scarring that stiffens the lungs. People may notice daily shortness of breath, reduced exercise capacity, and low oxygen levels during activity or sleep. Over time, this can resemble other forms of pulmonary fibrosis.
Extrapulmonary involvement
Less common, beryllium-related inflammation can affect skin or lymph nodes. People might see skin rashes at contact sites or enlarged lymph nodes along with lung symptoms. Not everyone will experience every type.
What genetics can tell you about symptoms
Certain HLA-DP gene variants, especially those with a glutamic acid at position 69 (HLA-DPB1 Glu69), can make the immune system overreact to beryllium. This raises the chance of cough, shortness of breath, chest tightness, and fatigue due to lung inflammation and scarring.
Causes and risk factors
Chronic beryllium disease is caused by breathing in beryllium dust or fumes, most often at work.
The immune system can become sensitized to beryllium and then start long‑lasting inflammation in the lungs.
Risk rises with higher or longer exposure, and certain immune system gene types, like HLA‑DP variants, can increase susceptibility.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Smoking and other lung irritants do not cause it, but they can worsen breathing and make it harder to notice early symptoms of chronic beryllium disease.
Environmental and biological risk factors
Breathing or handling beryllium at work is the main route of risk, while your immune system can shape how your body reacts. Doctors often group risks into internal (biological) and external (environmental). Below are the environmental and biological risk factors for chronic beryllium disease people most often encounter at work or at home. This is not about lifestyle choices, but about exposures and body-based responses.
Inhalation of fine beryllium particles is the leading exposure. Higher concentrations and frequent contact raise the chance of sensitization and chronic beryllium disease. Even low levels over time can matter.
The longer someone spends around beryllium, the greater the cumulative dose. Extended exposure increases the likelihood of developing chronic beryllium disease. Short, intense projects can also add meaningful risk.
Very small particles can reach the deepest parts of the lungs. Tasks that create ultrafine dust increase the chance of immune sensitization. These particles stay airborne longer and are easier to inhale.
Machining, grinding, welding, or abrasive blasting can generate clouds of respirable beryllium. These tasks often produce sudden spikes in dust. People nearby may be exposed even if they are not doing the task.
Genetic risk factors
Genetic risk factors for Chronic beryllium disease center on how your immune genes recognize beryllium. The strongest influence comes from versions of an immune gene called HLA‑DP, especially those with a change known as E69. Carrying a genetic change doesn’t guarantee the condition will appear. Genes may shape who becomes sensitized and how active the illness becomes, but they do not change the early symptoms of Chronic beryllium disease.
HLA-DP E69: A version of the HLA‑DP immune gene that includes E69 changes how the immune system presents beryllium to white blood cells. People who carry this version have a higher chance of developing Chronic beryllium disease. The strength of risk varies by the exact gene version.
Two-copy effect: Having the E69 version on both gene copies raises risk more than having it on just one. This dose-like pattern has been shown across multiple studies of Chronic beryllium disease. It can also relate to stronger immune reactivity.
High-expression alleles: Some HLA‑DP versions are displayed at higher levels on immune cells. Higher display can intensify the immune response in the lungs. These versions may be linked with more active inflammation.
HLA-DP pairing: The HLA‑DP protein is made from two parts, DPA1 and DPB1. Certain pairings with E69 bind beryllium more readily and increase susceptibility. Lab reports often list both parts together.
Other HLA genes: Variations in nearby HLA‑DR and HLA‑DQ genes can modestly influence who develops Chronic beryllium disease. Their effects are smaller and less consistent than HLA‑DP. They are not routinely used to estimate risk.
Family patterns: HLA types are inherited, so close relatives may share similar susceptibility variants. A family history can hint at shared genetic risk. Genetics alone does not determine illness.
Ancestry variation: The frequency of the HLA‑DP E69 variant differs across ancestries and populations. As a result, baseline genetic susceptibility to Chronic beryllium disease can vary between groups. Personal risk depends on your own genes.
Research genes: Scientists are studying other immune signaling genes, such as those affecting cytokines. So far, links with Chronic beryllium disease are mixed and not confirmed across different studies. These candidates are not part of standard risk testing.
Lifestyle risk factors
Daily habits can influence symptom control, flare frequency, and long‑term lung function in Chronic beryllium disease. Understanding lifestyle risk factors for Chronic beryllium disease can help you focus on changes that make breathing easier and reduce complications. Small, consistent adjustments often add up to meaningful gains in stamina and quality of life.
Tobacco or e‑cigarette use adds airway inflammation that can worsen cough and speed lung function decline in Chronic beryllium disease. Quitting lowers infection risk and may improve breathing efficiency.
A sedentary routine weakens respiratory and limb muscles, increasing breathlessness with everyday tasks. Regular, paced activity or pulmonary rehab can improve exercise tolerance and reduce symptom flare-ups.
Inadequate protein and calories promote muscle loss, including the muscles used for breathing. Meeting protein needs helps maintain strength and supports recovery during exacerbations.
Diets high in refined sugars, salt, and additives can drive systemic inflammation and fluid retention. This may intensify breathlessness and strain the heart in advanced lung disease.
Risk prevention
Most risk comes from breathing beryllium dust or fumes at work. Strong protection comes from reducing exposure, using the right gear, and keeping dust from leaving the worksite. Prevention works best when combined with regular check-ups. People at risk for chronic beryllium disease also benefit from training and early reporting of cough or shortness of breath.
Enclose or isolate dusty steps, and use local exhaust ventilation to capture beryllium at the source. Substituting materials and redesigning tasks can lower the chance of chronic beryllium disease.
Wear fit-tested respirators with the correct filters when ventilation alone cannot keep levels low. Keep facial hair clear of the seal and replace cartridges as scheduled to cut chronic beryllium disease risk.
Use wet methods and HEPA vacuums; avoid dry sweeping or compressed air that spreads dust. Good housekeeping reduces lingering particles that can trigger chronic beryllium disease.
Change out of work clothes, shower if available, and use on-site laundry so dust doesn’t come home. This protects families and lowers repeated exposure that can lead to chronic beryllium disease.
Transmission
Many wonder whether Chronic beryllium disease is contagious; it isn’t. The condition develops when someone breathes in very small beryllium particles or fumes, most often in workplaces that machine or process beryllium metal, alloys, or ceramics. You can’t catch Chronic beryllium disease from living with, touching, or caring for someone who has it. Beryllium dust can cling to skin, clothing, shoes, or hair and be carried home, which can expose family members to beryllium unless workplaces and workers use proper cleaning and protective steps. Certain inherited immune system differences can raise the risk after exposure, but the disease itself is not inherited or passed down.
When to test your genes
Test your genes if you’ve had significant beryllium exposure at work or home, especially in aerospace, machining, electronics, or mining. Screening for HLA-DPβ1 Glu69 (a known risk marker) can guide how closely you’re monitored and how quickly to investigate symptoms like cough or shortness of breath. Discuss testing if you’re beginning beryllium-related work or have persistent lung issues.
Diagnosis
You might notice small changes like a dry cough that lingers or feeling out of breath on stairs, especially after work around metal or electronics. For some, routine check-ups reveal the first clues. Getting to a diagnosis of chronic beryllium disease usually starts with your story and then moves to targeted lung tests and scans. The goal is to confirm beryllium sensitivity, show lung inflammation, and rule out look-alike conditions such as sarcoidosis.
Your provider asks about past and current jobs, tasks, and how beryllium might have been handled at work. Details about protective equipment and length of exposure help estimate risk.
A clinician reviews cough, chest tightness, wheeze, and activity limits, then listens for crackles in the lungs. They also look for signs like clubbing or low oxygen during exertion.
Imaging checks for patterns of lung inflammation and scarring typical of this condition. High‑resolution CT can show small nodules and airway changes that a standard X‑ray may miss.
Breathing tests measure airflow and how well oxygen moves into the blood. Results often show restriction or reduced gas transfer, which supports lung involvement.
Stages of Chronic beryllium disease
Chronic beryllium disease does not have defined progression stages. The course can vary—some people stay fairly stable for years, while others slowly develop more breathing trouble—so doctors track it by symptoms, lung function, and imaging rather than fixed stage labels. Different tests may be suggested to help confirm the diagnosis, such as reviewing work or hobby exposure to beryllium, a blood test that checks how the immune system reacts to beryllium, breathing tests, CT scans, and sometimes a small tissue sample from the lung. If early symptoms of chronic beryllium disease—like a dry cough, shortness of breath with activity, or unusual tiredness—appear, regular follow-up can help spot changes early and guide treatment.
Outlook and prognosis
Breathlessness during a walk, a cough that won’t quit, or feeling wiped out after climbing stairs can shape daily plans for people with Chronic beryllium disease. Many people ask, “What does this mean for my future?”, because symptoms can flare with infections or dust exposure and then settle for a while. Doctors call this the prognosis—a medical word for likely outcomes. With careful avoidance of beryllium, inhalers, and medicines that calm the immune reaction (often steroids with or without other agents), many stabilize or improve enough to keep up with work and family routines.
Over years, some develop scarring in the lungs that limits airflow and oxygen levels, while others remain relatively stable with minimal changes on testing. When thinking about the future, it helps to know that early symptoms of chronic beryllium disease, like shortness of breath on exertion and a dry cough, don’t always predict how quickly the condition will progress. Serious complications can include pulmonary hypertension, repeated lung infections, and, in advanced stages, respiratory failure. Mortality varies widely and is higher in those with significant scarring, low oxygen, or heart–lung strain; quitting smoking, staying current on vaccines, and prompt treatment of infections can lower those risks.
Even though it can feel overwhelming, many people maintain good quality of life with regular monitoring, pulmonary rehab, and strict beryllium avoidance. Understanding the prognosis can guide planning and highlight the value of early care, including oxygen when needed and timely escalation of therapy. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like, including how often to check lung function and what warning signs should trigger a call.
Long-term effects
Over years, breathing can become more limited, affecting walking uphill, carrying groceries, or keeping up at work. Long-term effects vary widely, and some people stay fairly stable while others notice slow changes. For some living with chronic beryllium disease, ongoing lung inflammation can lead to scarring and strain on the heart-lung system. Early symptoms of chronic beryllium disease can be subtle, so the long view focuses on how lungs function over time and whether complications arise.
Shortness of breath often appears first with stairs or hills and may slowly worsen. Daily tasks can start to feel harder as lung capacity declines. Some eventually feel winded even at rest.
A dry, persistent cough can linger for months or years. For many with chronic beryllium disease, coughing flares during infections or exposure to irritants.
Low oxygen and the effort of breathing can sap energy. People may need more breaks during chores or walks.
Ongoing inflammation can leave fibrous changes in the lungs over time. This scarring can make lungs stiffer and less efficient in chronic beryllium disease.
How is it to live with Chronic beryllium disease?
Living with chronic beryllium disease often means pacing your day around your lungs—shortness of breath with stairs, a lingering cough, and fatigue that can turn simple chores into planned events with rest breaks. Many find they monitor air quality, keep up with inhalers or steroids, and schedule regular checkups and breathing tests, which can affect work choices and social plans. Family, friends, and coworkers may notice limits on physical activities and the need to avoid certain exposures, but clear communication and practical support—like helping with errands or choosing low-exertion outings—can make daily life more manageable. With pulmonary rehab, vaccination, and consistent care, many people settle into routines that protect lung health while preserving connection and purpose.
Treatment and drugs
Chronic beryllium disease is managed by reducing ongoing exposure to beryllium, easing lung inflammation, and supporting breathing. Treatment often starts with corticosteroids like prednisone to calm inflammation in the lungs; a doctor may adjust your dose to balance benefits and side effects. If steroids aren’t enough or cause problems, other immune-suppressing medicines (such as methotrexate or azathioprine) may be added, and inhalers or oxygen therapy can help with shortness of breath during activity or sleep. Pulmonary rehabilitation, vaccines (flu and pneumonia), and not smoking are important parts of care, and regular check-ins track lung function and catch flare-ups early. Although living with chronic beryllium disease can feel overwhelming, supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Living with chronic beryllium disease can make everyday tasks—like climbing stairs or carrying groceries—feel harder. Alongside medicines, non-drug therapies can ease breathlessness, protect lung function, and support energy for daily life. These approaches focus on avoiding triggers, building stamina, and managing symptoms at home and work. Your care team can help tailor options to your goals and job demands.
Stop contact with beryllium to prevent the immune reaction from being triggered again. This often means changing tasks, work areas, or roles.
An occupational health review can identify safer job duties and protective gear. Respirators are a bridge, but getting out of exposure is the priority.
A supervised program builds endurance, trains breathing, and teaches pacing. It can reduce breathlessness and improve walking distance. Not every approach works the same way for everyone.
Methods like pursed‑lip and diaphragmatic breathing can make it easier to exhale and slow your breathing. Practicing these daily can help during activity or a flare of symptoms.
Your genes may have an impact on how drugs work for you
Some people process corticosteroids or immunosuppressants differently because of inherited differences in liver enzymes and immune-response genes, which can change how well the drugs work and the risk of side effects. Pharmacogenetic testing and careful monitoring help tailor doses for safer, more effective treatment.
Pharmacological treatments
Medical treatment for chronic beryllium disease aims to calm lung inflammation, protect breathing, and reduce flare-ups so daily activities feel easier. Not everyone responds to the same medication in the same way. Even if early symptoms of chronic beryllium disease are subtle, doctors may start medicines to prevent scarring and preserve lung function over time.
Often the first treatment to reduce lung inflammation and improve breathing. Dosing may be increased or lowered gradually to find the lowest effective amount. Side effects like mood changes, higher blood sugar, and bone thinning mean regular check-ins are important.
A steroid-sparing option taken weekly to maintain control and reduce prednisone needs. Blood tests monitor liver health and blood counts, and folic acid is usually added to limit side effects. Upset stomach or mouth sores can occur.
Another steroid-sparing medicine when methotrexate is not suitable or not enough. Regular blood and liver tests help track safety. Increased infection risk means prompt care for fevers or new symptoms.
Used when other steroid-sparing drugs are not tolerated or effective. It can help control ongoing inflammation and reduce steroid doses. Stomach upset is common, and reliable contraception is needed because it can harm a pregnancy.
Genetic influences
Risk for chronic beryllium disease isn’t just about how much beryllium you encountered; it also relates to how your immune system recognizes this metal. Genetics is only one piece of the puzzle, but certain immune-system gene types can make sensitization and lung inflammation more likely. Differences in immune-system genes—especially in a group called HLA—can lead the body to react more strongly to beryllium, raising the chance of sensitization and, over time, chronic beryllium disease. Even so, many people with these gene differences never get sick if they avoid exposure, and some without them can still develop the disease after high or prolonged exposure. For this reason, family history by itself is not a strong predictor; shared workplaces or hobbies often explain why several relatives might be affected. Genetic testing can look for these gene types, but it cannot confirm or rule out chronic beryllium disease and isn’t a substitute for medical evaluation of beryllium sensitization. If you’re considering genetic testing for chronic beryllium disease risk, a genetic counselor or occupational lung specialist can help you understand what the results do—and don’t—mean for your health decisions.
Is Chronic beryllium disease genetic?
Genetics play a modest role in chronic beryllium disease. A specific HLA-DP variant (often written HLA-DPB1 Glu69) increases susceptibility, but exposure drives risk. Not everyone with the variant gets sick, and people without it can still develop disease.
Pharmacogenetics—how genetics influence drug effects
For Chronic beryllium disease, genetics most strongly influences who becomes sensitized and develops the condition: certain differences in an immune system gene called HLA‑DP make the body more likely to recognize beryllium and drive ongoing lung inflammation. This insight mainly helps with prevention and workplace counseling; once the disease is present, treatment still focuses on removing exposure and calming inflammation with corticosteroids. There isn’t a proven genetic test to choose a specific steroid or dose for Chronic beryllium disease, and responses can vary for many reasons beyond genes. When doctors use steroid‑sparing medicines such as azathioprine, though, established pharmacogenetic tests (TPMT and NUDT15) can guide dosing and lower the risk of severe side effects like very low white blood cells. Alongside medical history and lung testing, genetic testing can sometimes add context about risk and how your body handles certain add‑on medicines. Put simply, pharmacogenetic testing for Chronic beryllium disease isn’t standard today, but it may be helpful if you need a thiopurine like azathioprine or take multiple medicines with known drug–gene interactions.
Interactions with other conditions
Breathing problems from chronic beryllium disease often feel worse when another lung condition is also in the mix. Doctors call it a “comorbidity” when two conditions occur together. Asthma, chronic bronchitis or COPD, and even prior smoking can all amplify shortness of breath, cough, and chest tightness; chest infections like the flu or pneumonia can trigger sudden flare‑ups. Chronic beryllium disease can also be mistaken for sarcoidosis because both can cause granulomas and similar scan findings, so early symptoms of chronic beryllium disease may blend into those from another diagnosis. If treatment requires steroids or other immune‑dampening medicines, that can raise blood sugar, thin bones, and increase infection risk, which matters for people also living with diabetes, osteoporosis, or latent tuberculosis. When conditions like pulmonary hypertension or sleep apnea are present alongside chronic beryllium disease, fatigue, oxygen needs, and exercise tolerance can change quickly, so coordinated follow‑up with all involved specialists is important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described persistent cough and breathlessness in metalworkers and miners, long before the cause was known. In workshops and factory floors, some workers noticed that the short walk they used to manage now left them winded, or that a lingering “chest cold” never truly cleared. Families and communities once noticed patterns in those who shaped alloys or handled fluorescent lamp materials, even when the connection to beryllium wasn’t obvious.
First described in the medical literature as a lung problem among beryllium-exposed workers in the 1930s and 1940s, early reports focused on severe cases tied to high levels of dust. At first, people thought the lungs were simply irritated or scarred by particles. Over time, doctors recognized a different process: the immune system becoming sensitized to beryllium, then causing long‑lasting inflammation in the lungs. This evolving picture marked the shift from acute poison-like reactions to what we now call chronic beryllium disease.
From early theories to modern research, the story of chronic beryllium disease shows how workplace observation and science moved together. In the mid‑20th century, as industries expanded, clusters of illness around refineries, ceramics, electronics, and aerospace prompted investigations. Reducing airborne dust cut the dramatic, sudden cases, but some workers still developed slowly progressive symptoms years after exposure. This helped confirm that even low or intermittent exposure could trigger a delayed immune response in people who became sensitized.
In recent decades, knowledge has built on a long tradition of observation. Tests were developed to detect immune sensitization to beryllium, which allowed earlier identification of at‑risk workers. Lung biopsy studies showed tiny inflammatory clusters called granulomas, similar to those seen in sarcoidosis, but tied to beryllium exposure. Researchers also learned that a person’s genetic makeup can influence susceptibility, clarifying why only some exposed workers develop chronic beryllium disease while others do not.
Medical classifications changed as understanding improved. What began as a single “beryllium lung” diagnosis branched into acute beryllium disease from heavy short‑term exposure and chronic beryllium disease from an ongoing immune reaction, often after lower or longer exposures. With this shift came stronger workplace standards, better air monitoring, and protective practices that reduced new cases, though chronic beryllium disease still occurs in certain settings.
Knowing the condition’s history helps explain today’s approach: identify exposure early, test for sensitization, and manage inflammation before scarring builds. The arc from factory observations to immune testing reflects a broader truth in occupational medicine—watching patterns, listening to workers’ experiences, and steadily refining the science can change outcomes for generations.